Dr. Milana Frenkel-Morgenstern

There are currently no licensed vaccines available for COVID-19.  While several antiviral drugs have been tested, none has proved to be completely effective against the disease. In a study just published in the journal MDPI Vaccines, researchers from Bar-Ilan University have identified a set of potential immunodominant epitopes from the SARS-CoV-2 proteome.  These epitopes are capable…

Read More
בזיליקום עמיד

Researchers of Bar-Ilan University, in cooperation with Genesis Seeds Ltd., have developed a hybrid of basil, the culinary herb, which is completely resistant to Downy Mildew, a devastating disease caused by a fungus-like pathogen. The new patented product, contains no pesticides and will provide much-needed relief to farmers and consumers worldwide.   In recent years an…

Read More
Isotopia Company and Prof. Rachela Popovtzer of Bar-Ilan University are developing an innovative method for diagnosis and treatment of cancer

The Israeli Isotopia Company, in collaboration with Prof. Rachela Popovtzer of Bar-Ilan University, is conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer.   The goal of this research is to facilitate, for the first time, the distinction between tumors and inflammation. The most common imaging method for…

Read More
CogniFiber has been selected to take part in Intel's Ingenuity Partner Program (Intel IPP)

As part of the program, CogniFiber will be mentored by experts from Intel’s business organizations, will be exposed to state-of-the-art technology, along with an educational infrastructure and local and international events. CogniFiber has been chosen to participate in the fourth cycle of Intel’s prestigious program for leveraging startups. The program’s framework is based on a…

Read More

BIRAD – RESEARCH & DEVELOPMENT COMPANY LTD. BIRAD –  Research & Development Company Ltd. was established in order to translate new inventions made at Bar-Ilan University into useful products that can be effectively commercialized, thus strengthening the economy, promoting innovation and improving lives. Our innovative approach, combined with Bar-Ilan University’s rapid growth, including the largest…

Read More
Prof. Jean-Paul Moshe Lellouche

  Nano-Drops May Offer New Alternative to Current Methods of Vision Correction Ramat Gan, Israel — A revolutionary, cutting-edge technology, developed by researchers at Bar-Ilan University’s Institute of Nanotechnology and Advanced Materials (BINA), has the potential to provide a new alternative to eyeglasses, contact lenses, and laser correction for refractive errors. The technology, known as Nano-Drops,…

Read More
זאב זלבסקי

Company recognized for its development by Bar-Ilan University engineering professor of a biometric sensing system that detects biomedical parameters from a distance without human contact Israeli start-up ContinUse Biometrics is among the ten first-place winners of the prestigious 2018 Prism Award (the Oscar of the photonics industry) for the Medical and Health category.  The company…

Read More